Stratrix
On the Record · Neurocrine Biosciences

Neurocrine Biosciences subsidiaries, as it lists them

The subsidiaries Neurocrine Biosciences lists in its latest annual report, with the jurisdiction of each, linked to the filing.

Subsidiaries it lists

SubsidiaryJurisdiction
Neurocrine Continental, Inc.Delaware, USA
Neurocrine International, Inc.Delaware, USA
Neurocrine Holdings LimitedEngland and Wales
Neurocrine Ireland LimitedIreland
Neurocrine Therapeutics LimitedIreland
Neurocrine Switzerland GmbHSwitzerland

From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.

Read from Neurocrine Biosciences’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-11. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.